Lundbeck has announced that Jacob Tolstrup, Executive Vice President for Commercial Operations, is promoted to Chief Commercial Officer, effective 1 January 2022.
Jacob will be responsible for sales and marketing across all Lundbeck affiliates worldwide. Also, Peter Anastasiou, Executive Vice President for North America, has decided to leave Lundbeck at the end of the year for another career opportunity that will be announced in the near future.
“I am pleased that we have internal talent to step up to the Chief Commercial Officer role. We will immediately benefit from Jacob’s in-depth knowledge of Lundbeck and extensive experience in global markets. Consolidating all our affiliates into one organization will enable us to seamlessly coordinate across our markets as we forge ahead with executing our strategy. I would like to take this opportunity to thank Peter for his many years of service to Lundbeck and to our patients. He has been an asset to our leadership team, instrumental in growing North America and he departs us with our North America business in a position of strength. I wish him every success in his future endeavors,” says Deborah Dunsire, CEO of Lundbeck.
Jacob Tolstrup has been with Lundbeck for over 20 years and has held a variety of roles and management positions across the company. He has been a member of the Executive Management team at Lundbeck since 2012. During his career, Jacob spent 4 years in the United States including a period as Head of Finance between 2010-2012. Since 2017, Jacob has been Executive Vice President, Head of Commercial Operations, which includes Global Strategic Marketing and all markets outside of North America (Europe and International Markets).
Jacob holds a Master of Science in Business Administration and Commercial Law as well as an MBA. He also serves as Chairman of the Board of Directors of Pharmacosmos A/S.
Photo of Jacob Tolstrup and Peter Anastasiou: Lundbeck